Australia’s CSL aims to acquire Swiss pharmaceutical company Vifor
December 17, 2021 at 05:29 PM
2 minute read
Correspondent, Sydney
Swiss law firm Homburger, international firm Simpson Thacher & Bartlett and Australia’s Allens are all advising CSL on its proposed $11.7 billion acquisition of Swiss pharmaceutical company Vifor.
CSL, an Australian serum manufacturer, has made an all-cash offer for Vifor Pharma, which is being advised by Switzerland’s Bär & Karrer.
Presented by BigVoodoo
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
The University of New Mexico (UNM) (https://www.unm.edu/) is seeking nominations, inquiries, and applications for the position of General Co...
Maslon LLP is seeking attorney candidates with 4-6 years of experience to join its Insurance Coverage Team. Maslon s Insurance Recovery Grou...
New York-based indie music company seeks full-time litigation attorney. Must have 2 years music business experience. Must be admitted to S...
Partial view of the Vifor Pharma Group headquarters in Switzerland. Credit: Judith Linine/Shutterstock.com
